Subscribe

Tonix Pharmaceuticals Holding Corp. (TNXP)

USD11.41 +0.35 (+3.12%)
US NASDAQ Healthcare Biotechnology
Address 26 Main Street 7928
Chatham, NJ, US
CEO Seth Lederman
IPO 2012-05-10
CIK 1430306 ISIN US8902608392

Explore sections of this company profile

Description

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treatments spanning several key medical fields: immunology, rare conditions, infectious diseases, and central nervous system (CNS) disorders. In the realm of immunology, Tonix is progressing with biologics designed to address organ transplant rejection, various autoimmune diseases, and certain forms of cancer. A prominent candidate here is TNX-1500, a humanized monoclonal antibody targeting CD40-ligand, which is being investigated for its utility in preventing both allograft and xenograft rejection, as well as in treating autoimmune disorders. Its rare disease initiatives include TNX-2900, a specific treatment candidate for Prader-Willi syndrome. The infectious disease segment features a diverse array of programs: TNX-801, a vaccine designed to offer protection against smallpox and monkeypox. TNX-1840 and TNX-1850, which are live virus vaccines based on the company's recombinant pox vaccine (RPV) platform, targeting COVID-19. TNX-3500, a small molecule antiviral drug for the treatment of acute COVID-19. TNX-102 SL, a small molecule medication under investigation for Long COVID, a persistent post-acute COVID-19 condition. Finally, the CNS portfolio encompasses both small molecules and biologics intended to manage pain, neurological conditions, psychiatric ailments, and addiction. Notably, TNX-102 SL is also in mid-Phase 3 development for alleviating fibromyalgia symptoms. Other CNS candidates include TNX-1900, which is being developed to prevent migraine headaches, and TNX-1300, a biologic aimed at treating cocaine intoxication. The company was established in 2007 and maintains its headquarters in Chatham, New Jersey.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD11.41 +0.35 (+3.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
485.6K
Beta
1.68
Float Shares
13.38M
Free Float %
94.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.14% +0.79% +13.06% -11.03% -19.51% -9.67% -26.47% -99.75% -100.00% -100.00% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (7 ratings, all time) Buy
Price Targets & DCF
Current price
11.41
DCF (Unlevered) 24.44 +114.3%
DCF (Levered) 12.25 +7.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 3 +1
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-1.98
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    +29.9% Q1'26: +183.2% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    +91.8% Q1'26: -3.2% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -880.5% Q1'26: -639.9% (vs Q1'25)
  • EBIT margin Biotechnology: +0.0%
    -959.1% Q1'26: +0.0% (vs Q1'25)
  • ROIC Biotechnology: -16.1%
    -323.8%
  • Share dilution Biotechnology: -3.4%
    +276.0% Q1'26: +131.3% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.01× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.69) × ERP
WACC = 99% × Ke + 1% × Kd (6.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 24.44 Current price: 11.41
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
2 EPS Ana.
Dec 2027
2 Rev. Ana.
2 EPS Ana.
Dec 2028
3 Rev. Ana.
2 EPS Ana.
Dec 2029
2 Rev. Ana.
1 EPS Ana.
Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
7.77M
est: 12.46M (-37.6%)
10.09M
est: 12.80M (-21.1%)
13.11M
est: 10.43M (+25.6%)
30.39M
15.63M – 49.71M
+191.2% YoY
81.58M
70.73M – 92.43M
+168.5% YoY
176.29M
176.29M – 176.29M
+116.1% YoY
157.57M
116.07M – 214.46M
-10.6% YoY
213.42M
157.21M – 290.47M
+35.4% YoY
EBITDA
-114.09M
est: -2.49M (-4,478.9%)
-74.32M
est: -2.56M (-2,803.2%)
-123.78M
est: -2.09M (-5,831.9%)
-6.08M
-9.94M – -3.13M
-191.2% YoY
-16.32M
-18.49M – -14.15M
-168.5% YoY
-35.26M
-35.26M – -35.26M
-116.1% YoY
-31.51M
-42.89M – -23.21M
+10.6% YoY
-42.68M
-58.09M – -31.44M
-35.4% YoY
EBIT
-118.38M
est: -2.49M (-4,651.2%)
-77.74M
est: -2.56M (-2,936.9%)
-125.70M
est: -2.09M (-5,924.1%)
-6.08M
-9.94M – -3.13M
-191.2% YoY
-16.32M
-18.49M – -14.15M
-168.5% YoY
-35.26M
-35.26M – -35.26M
-116.1% YoY
-31.51M
-42.89M – -23.21M
+10.6% YoY
-42.68M
-58.09M – -31.44M
-35.4% YoY
Net Income
-116.66M
est: -687.68M (+83.0%)
-130.04M
est: -81.42M (-59.7%)
-124.02M
est: -114.95M (-7.9%)
-79.89M
-96.00M – -63.79M
+30.5% YoY
-57.10M
-79.43M – -34.78M
+28.5% YoY
-36.00M
-62.13M – 23.09M
+37.0% YoY
-28.51M
-41.89M – -18.75M
+20.8% YoY
8.09M
5.32M – 11.88M
+128.4% YoY
SGA
34.75M
est: 42.70M (-18.6%)
40.10M
est: 43.87M (-8.6%)
87.68M
est: 35.76M (+145.2%)
104.14M
53.56M – 170.37M
+191.2% YoY
279.59M
242.42M – 316.77M
+168.5% YoY
604.20M
604.20M – 604.20M
+116.1% YoY
540.04M
397.81M – 735.01M
-10.6% YoY
731.44M
538.81M – 995.51M
+35.4% YoY
EPS
-6,368.84
est: -75.97 (-8,283.1%)
-176.60
est: -113.50 (-55.6%)
-14.57
est: -13.43 (-8.5%)
-9.51
-11.28 – -7.49
+29.2% YoY
-6.38
-9.33 – -4.09
+32.9% YoY
-2.29
-7.30 – 2.71
+64.1% YoY
-3.35
-4.92 – -2.20
-46.1% YoY
0.95
0.62 – 1.40
+128.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B- 3/5 4/5 1/5 1/5 4/5 1/5 4/5
2026-05-08 B 3/5 4/5 1/5 1/5 4/5 1/5 5/5
2026-05-07 B 3/5 4/5 1/5 1/5 4/5 1/5 5/5
2026-05-06 B 3/5 4/5 1/5 1/5 4/5 1/5 5/5
2026-05-05 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-05-04 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-05-01 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-30 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-29 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-28 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-27 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-24 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-23 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-04-22 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-04-21 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-04-20 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-04-17 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-04-16 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-50.14M
OE per share TTM
-6.36
Owner's Yield
-26.60%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
1,098.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
15
Total invested
5.27M
Insider transactions (90d)
0
Beneficial owners (>5%)
25
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 (1)Names of reporting persons. BlackRock, Inc. 30.63M 6.20% 29.52M 30.63M HC Delaware 2022-02-04
2 Alyeska Fund GP, LLC 5.86M 9.99% 5.86M OO Delaware 2024-02-14
3 Alyeska Investment Group, L.P. 5.86M 9.99% 5.86M IA Delaware 2024-02-14
4 Anand Parekh 5.86M 9.99% 5.86M IN United States of America 2024-02-14
5 TANG CAPITAL PARTNERS, LP 4.28M 7.40% 4.28M 4.28M UNITED STATES 2022-12-27
6 Armistice Capital, LLC 3.77M 6.71% 3.77M IA, OO Delaware 2024-02-14
7 Steven Boyd 3.77M 6.71% 3.77M HC, IN United States of America 2024-02-14
8 Empery Asset Management, LP 1.74M 1.34% 1.74M PN Delaware 2024-10-16
9 Martin D. Hoe 1.74M 1.34% 1.74M IN United States 2024-10-16
10 Ryan M. Lane 1.74M 1.34% 1.74M IN United States 2024-10-16
11 Armistice Capital Master Fund Ltd. 598.4K 9.99% 598.4K 598.4K CO 2020-02-14
12 L1 Capital Global Opportunities Master Fund, Ltd. 432.2K 9.99% 432.2K FI Cayman Islands 2024-06-20
13 (1) BlackRock, Inc. 341.7K 1.10% 328.3K 341.7K HC Delaware 2022-07-08
14 13-3127734 271.2K 0.14% 271.2K 271.2K HC Delaware 2021-02-11
15 26-0385758 271.2K 0.14% 271.2K 271.2K IA Delaware 2021-02-11
16 13G 150.0K 6.30% 150.0K 150.0K IN Texas 2018-12-20
17 CVI Investments, Inc. 111.3K 0.10% 111.3K 111.3K CO Delaware 2021-02-16
18 Heights Capital Management, Inc. 111.3K 0.10% 111.3K 111.3K CO Delaware 2021-02-16
19 Richard Abbe 100.0K 2.40% 64.3K 35.7K 64.3K 100.0K HC, IN United States of America 2020-02-14
20 Iroquois Capital Management L.L.C. 35.7K 1.00% 35.7K 35.7K OO Delaware 2020-02-14
21 Kimberly Page 35.7K 1.00% 35.7K 35.7K IN United States of America 2020-02-14
22 Altium Capital Management, LP 0.00% IA, PN Delaware, United States of America 2021-02-11
23 Altium Growth Fund, LP 0.00% PN Delaware, United States of America 2021-02-11
24 Altium Growth GP, LLC 0.00% OO Delaware, United States of America 2021-02-11
25 Iridian Asset Management LLC 0.00% 78.6K 78.6K IA, IN Cayman Islands 2020-01-21

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
15
-60 vs prev Q
New positions
4
Closed positions
60
Increased
10
Reduced
2
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 BLACKROCK, INC. 884.9K +203.4K (+29.8%) 13.82M -2.6M (-16.1%) 9.92% +0.616 pp 0.00% 0.000 pp USD26.39 -40.8% 4 qtrs
2 VANGUARD GROUP INC 673.6K +116.6K (+20.9%) 10.52M -2.9M (-21.8%) 7.55% -0.052 pp 0.00% +0.000 pp USD23.11 -32.4% 4 qtrs
3 POINT72 ASSET MANAGEMENT, L.P. 620.0K +620.0K (+100.0%) 9.68M +9.7M (+100.0%) 6.95% +6.949 pp 0.01% +0.011 pp USD15.62 +0.0% 1 qtrs NEW
4 GEODE CAPITAL MANAGEMENT, LLC 271.9K +71.0K (+35.3%) 4.25M -607.2K (-12.5%) 3.05% +0.305 pp 0.00% +0.000 pp USD25.42 -38.6% 4 qtrs
5 STATE STREET CORP 191.9K +39.3K (+25.8%) 3.00M -688.7K (-18.7%) 2.15% +0.068 pp 0.00% +0.000 pp USD28.11 -44.4% 4 qtrs
6 BALYASNY ASSET MANAGEMENT L.P. 185.4K +185.4K (+100.0%) 2.90M +2.9M (+100.0%) 2.08% +2.077 pp 0.00% +0.004 pp USD15.62 +0.0% 1 qtrs NEW
7 NORTHERN TRUST CORP 174.9K +5.2K (+3.1%) 2.73M -1.4M (-33.4%) 1.96% -0.356 pp 0.00% 0.000 pp USD33.64 -53.6% 4 qtrs
8 NUVEEN, LLC 93.4K +78.0K (+507.7%) 1.46M +1.1M (+292.9%) 1.05% +0.837 pp 0.00% +0.000 pp USD18.97 -17.7% 3 qtrs
9 UBS GROUP AG 91.5K +39.9K (+77.3%) 1.43M +182.4K (+14.6%) 1.03% +0.321 pp 0.00% +0.000 pp USD19.39 -19.4% 4 qtrs
10 DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 90.0K +90.0K (+100.0%) 1.41M +1.4M (+100.0%) 1.01% +1.009 pp 0.02% +0.022 pp USD15.62 +0.0% 1 qtrs NEW
11 MORGAN STANLEY 42.0K +26.4K (+168.2%) 656.6K +277.9K (+73.4%) 0.47% +0.257 pp 0.00% +0.000 pp USD22.26 -29.8% 4 qtrs
12 CITADEL ADVISORS LLC 39.8K +39.8K (+100.0%) 621.7K +621.7K (+100.0%) 0.45% +0.446 pp 0.00% +0.000 pp USD15.62 +0.0% 1 qtrs NEW
13 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 33.4K +6.6K (+24.7%) 521.8K -125.5K (-19.4%) 0.37% +0.009 pp 0.00% +0.000 pp USD30.16 -48.2% 3 qtrs
14 BANK OF AMERICA CORP /DE/ 30.3K +25.7K (+551.8%) 473.5K +361.1K (+321.4%) 0.34% +0.276 pp 0.00% +0.000 pp USD16.20 -3.6% 4 qtrs
15 GOLDMAN SACHS GROUP INC 26.8K +14.1K (+110.7%) 418.7K +111.4K (+36.2%) 0.30% +0.127 pp 0.00% +0.000 pp USD19.67 -20.6% 2 qtrs
16 BANK OF NEW YORK MELLON CORP 24.1K +3.9K (+19.5%) 375.9K -110.8K (-22.8%) 0.27% -0.005 pp 0.00% +0.000 pp USD31.49 -50.4% 3 qtrs
17 SUSQUEHANNA INTERNATIONAL GROUP, LLP 23.4K +1.8K (+8.3%) 365.5K -156.3K (-30.0%) 0.26% -0.033 pp 0.00% +0.000 pp USD23.50 -33.5% 2 qtrs
18 MILLENNIUM MANAGEMENT LLC 22.9K -29.8K (-56.5%) 358.4K -915.6K (-71.9%) 0.26% -0.463 pp 0.00% 0.000 pp USD23.10 -32.4% 4 qtrs
19 BARCLAYS PLC 22.2K +9.8K (+78.3%) 347.2K +46.1K (+15.3%) 0.25% +0.079 pp 0.00% +0.000 pp USD27.04 -42.2% 3 qtrs
20 AQR CAPITAL MANAGEMENT LLC 20.0K +20.0K (+100.0%) 312.7K +312.7K (+100.0%) 0.22% +0.224 pp 0.00% +0.000 pp USD15.62 +0.0% 1 qtrs NEW
21 MAN GROUP PLC 18.4K +18.4K (+100.0%) 288.1K +288.1K (+100.0%) 0.21% +0.207 pp 0.00% +0.001 pp USD15.62 +0.0% 1 qtrs NEW
22 WELLS FARGO & COMPANY/MN 15.4K +8.2K (+114.6%) 241.0K +67.3K (+38.7%) 0.17% +0.075 pp 0.00% +0.000 pp USD23.32 -33.0% 3 qtrs
23 JANE STREET GROUP, LLC 15.1K +15.1K (+100.0%) 235.9K +235.9K (+100.0%) 0.17% +0.169 pp 0.00% +0.000 pp USD15.62 +0.0% 1 qtrs NEW
24 ENGINEERS GATE MANAGER LP 14.3K +5.6K (+63.7%) 222.8K +12.3K (+5.8%) 0.16% +0.041 pp 0.00% +0.000 pp USD20.84 -25.0% 2 qtrs
25 ALLIANCEBERNSTEIN L.P. 13.1K +— (+0.0%) 204.2K -111.6K (-35.3%) 0.15% -0.032 pp 0.00% +0.000 pp USD35.98 -56.6% 3 qtrs
26 AMERICAN CENTURY COMPANIES INC 12.9K +2.8K (+27.9%) 200.7K -41.9K (-17.3%) 0.14% +0.007 pp 0.00% +0.000 pp USD22.30 -30.0% 2 qtrs
27 RHUMBLINE ADVISERS 12.7K +529.0 (+4.3%) 198.9K -96.0K (-32.5%) 0.14% -0.024 pp 0.00% 0.000 pp USD18.23 -14.3% 4 qtrs
28 SEI INVESTMENTS CO 11.0K +11.0K (+100.0%) 171.4K +171.4K (+100.0%) 0.12% +0.123 pp 0.00% +0.000 pp USD15.62 +0.0% 1 qtrs NEW
29 PRICE T ROWE ASSOCIATES INC /MD/ 10.9K +10.9K (+100.0%) 171.0K +171.0K (+100.0%) 0.12% +0.123 pp 0.00% +0.000 pp USD15.62 +0.0% 1 qtrs NEW
30 LOS ANGELES CAPITAL MANAGEMENT LLC 9.3K +9.3K (+100.0%) 167.4K +167.4K (+100.0%) 0.10% +0.104 pp 0.00% +0.001 pp USD15.62 +0.0% 1 qtrs NEW
31 NISA INVESTMENT ADVISORS, LLC 10.0K -4.8K (-32.4%) 156.2K -201.4K (-56.3%) 0.11% -0.090 pp 0.00% -0.001 pp USD24.16 -35.3% 2 qtrs
32 STRS OHIO 7.8K +700.0 (+9.9%) 121.8K -49.7K (-29.0%) 0.09% -0.010 pp 0.00% 0.000 pp USD27.64 -43.5% 3 qtrs
33 5.7K +5.0K (+714.3%) 89.0K +72.1K (+426.5%) 0.06% +0.054 pp 0.00% +0.002 pp USD16.67 -6.3% 2 qtrs
34 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 5.4K +1.3K (+31.0%) 84.2K -15.2K (-15.3%) 0.06% +0.004 pp 0.00% +0.000 pp USD31.16 -49.9% 3 qtrs
35 JPMORGAN CHASE & CO 4.7K +653.0 (+16.3%) 72.9K -24.1K (-24.8%) 0.05% -0.003 pp 0.00% +0.000 pp USD32.02 -51.2% 3 qtrs
36 METLIFE INVESTMENT MANAGEMENT, LLC 4.6K +— (+0.0%) 72.1K -39.4K (-35.3%) 0.05% -0.011 pp 0.00% 0.000 pp USD35.98 -56.6% 3 qtrs
37 NEW YORK STATE COMMON RETIREMENT FUND 2.9K +— (+0.0%) 45.3K -24.8K (-35.3%) 0.03% -0.007 pp 0.00% +0.000 pp USD35.98 -56.6% 3 qtrs
38 BNP PARIBAS ARBITRAGE, SNC 2.5K +745.0 (+43.1%) 38.6K -3.1K (-7.5%) 0.03% +0.004 pp 0.00% +0.000 pp USD29.85 -47.7% 3 qtrs
39 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 2.4K +— (+0.0%) 37.7K -20.6K (-35.3%) 0.03% -0.006 pp 0.00% 0.000 pp USD32.63 -52.1% 3 qtrs
40 STATE OF WYOMING 1.7K +1.7K (+100.0%) 27.3K +27.3K (+100.0%) 0.02% +0.020 pp 0.00% +0.003 pp USD15.62 +0.0% 1 qtrs NEW
41 GROUP ONE TRADING, L.P. 1.7K +1.2K (+292.4%) 25.9K +15.7K (+153.7%) 0.02% +0.013 pp 0.00% +0.000 pp USD17.80 -12.2% 2 qtrs
42 ADVISOR GROUP HOLDINGS, INC. 1.5K +3.0 (+0.2%) 24.1K -14.9K (-38.2%) 0.02% -0.004 pp 0.00% +0.000 pp USD26.53 -41.1% 4 qtrs
43 FMR LLC 1.5K -44.0K (-96.7%) 23.5K -1.1M (-97.9%) 0.02% -0.604 pp 0.00% 0.000 pp USD27.48 -43.2% 3 qtrs
44 TOWER RESEARCH CAPITAL LLC (TRC) 1.4K -2.0K (-58.8%) 22.3K -61.3K (-73.4%) 0.02% -0.031 pp 0.00% -0.002 pp USD27.30 -42.8% 4 qtrs
45 RUSSELL INVESTMENTS GROUP, LTD. 1.3K +66.0 (+5.5%) 19.7K -9.2K (-31.8%) 0.01% -0.002 pp 0.00% +0.000 pp USD23.71 -34.1% 2 qtrs
46 LEGAL & GENERAL GROUP PLC 1.1K +220.0 (+26.4%) 16.4K -3.7K (-18.3%) 0.01% +0.000 pp 0.00% +0.000 pp USD30.11 -48.1% 3 qtrs
47 AMERITAS INVESTMENT PARTNERS, INC. 773.00 +— (+0.0%) 12.1K -6.6K (-35.4%) 0.01% -0.002 pp 0.00% 0.000 pp USD35.98 -56.6% 3 qtrs
48 STERLING CAPITAL MANAGEMENT LLC 734.00 +123.0 (+20.1%) 11.5K -3.3K (-22.3%) 0.01% 0.000 pp 0.00% +0.000 pp USD26.01 -39.9% 3 qtrs
49 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 715.00 +242.0 (+51.2%) 11.2K -260.0 (-2.3%) 0.01% +0.002 pp 0.00% +0.000 pp USD29.07 -46.3% 3 qtrs
50 GEN-WEALTH PARTNERS INC 533.00 +— (+0.0%) 8.3K -4.6K (-35.3%) 0.01% -0.001 pp 0.00% -0.002 pp USD24.16 -35.3% 2 qtrs
51 DEUTSCHE BANK AG\ 507.00 -5.4K (-91.4%) 7.9K -134.6K (-94.4%) 0.01% -0.075 pp 0.00% +0.000 pp USD34.46 -54.7% 3 qtrs
52 AMALGAMATED BANK 365.00 +107.0 (+41.5%) 6.0K +— (+0.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD30.01 -48.0% 3 qtrs
53 ROYAL BANK OF CANADA 338.00 +66.0 (+24.3%) 6.0K +— (+0.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD17.43 -10.4% 4 qtrs
54 PINNACLE WEALTH PLANNING SERVICES, INC. 342.00 +342.0 (+100.0%) 5.3K +5.3K (+100.0%) 0.00% +0.004 pp 0.00% +0.001 pp USD15.62 +0.0% 1 qtrs NEW
55 CITIGROUP INC 341.00 +92.0 (+36.9%) 5.3K -690.0 (-11.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD29.85 -47.7% 4 qtrs
56 IFP ADVISORS, INC 300.00 +100.0 (+50.0%) 4.7K -146.0 (-3.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD21.31 -26.7% 2 qtrs
57 CWM, LLC 217.00 +191.0 (+734.6%) 3.0K +2.0K (+200.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD16.64 -6.1% 2 qtrs
58 FARTHER FINANCE ADVISORS, LLC 148.00 +148.0 (+100.0%) 2.3K +2.3K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD15.61 +0.1% 1 qtrs NEW
59 DOGWOOD WEALTH MANAGEMENT LLC 110.00 +— (+0.0%) 1.7K -940.0 (-35.4%) 0.00% 0.000 pp 0.00% -0.001 pp USD24.15 -35.3% 2 qtrs
60 FEDERATION DES CAISSES DESJARDINS DU QUEBEC 108.00 -87.0 (-44.6%) 1.7K -3.0K (-64.2%) 0.00% -0.002 pp 0.00% +0.000 pp USD25.97 -39.9% 3 qtrs
61 CAITLIN JOHN, LLC 77.00 +77.0 (+100.0%) 1.2K +1.2K (+100.0%) 0.00% +0.001 pp 0.00% +0.001 pp USD15.61 +0.1% 1 qtrs NEW
62 SBI SECURITIES CO., LTD. 76.00 -120.0 (-61.2%) 1.2K -3.5K (-74.9%) 0.00% -0.002 pp 0.00% 0.000 pp USD19.12 -18.3% 4 qtrs
63 NORTH STAR INVESTMENT MANAGEMENT CORP. 52.00 +— (+0.0%) 812.00 -444.0 (-35.4%) 0.00% 0.000 pp 0.00% +0.000 pp USD0.33 +4,633.3% 5 qtrs
64 ROCKEFELLER CAPITAL MANAGEMENT L.P. 40.00 +14.0 (+53.8%) 625.00 -3.0 (-0.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD21.15 -26.1% 2 qtrs
65 SRS CAPITAL ADVISORS, INC. 12.00 -117.0 (-90.7%) 187.00 -2.9K (-94.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD24.08 -35.1% 2 qtrs
66 ALLWORTH FINANCIAL LP 10.00 +10.0 (+100.0%) 157.00 +157.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD15.60 +0.1% 1 qtrs NEW
67 SUNBELT SECURITIES, INC. 5.00 +5.0 (+100.0%) 78.00 +78.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD15.60 +0.1% 1 qtrs NEW
68 ASSETMARK, INC 3.00 +— (+0.0%) 47.00 -25.0 (-34.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD17.67 -11.6% 4 qtrs
69 EVERSOURCE WEALTH ADVISORS, LLC 1.00 +1.0 (+100.0%) 16.00 +16.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD15.00 +4.1% 1 qtrs NEW
70 ROTHSCHILD INVESTMENT LLC 1.00 +1.0 (+100.0%) 16.00 +16.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD15.00 +4.1% 1 qtrs NEW
71 SQUAREPOINT OPS LLC -31.6K (-100.0%) -764.3K (-100.0%) 0.00% -0.432 pp 0.00% -0.001 pp USD 2 qtrs SOLD
72 CIBC ASSET MANAGEMENT INC -17.6K (-100.0%) -424.4K (-100.0%) 0.00% -0.240 pp 0.00% -0.001 pp USD 4 qtrs SOLD
73 ABACUS WEALTH PARTNERS, LLC -15.0K (-100.0%) -362.4K (-100.0%) 0.00% -0.205 pp 0.00% -0.052 pp USD 2 qtrs SOLD
74 WELLINGTON MANAGEMENT GROUP LLP -26.5K (-100.0%) -639.4K (-100.0%) 0.00% -0.361 pp 0.00% 0.000 pp USD 2 qtrs SOLD
75 CAPITAL FUND MANAGEMENT S.A. -62.9K (-100.0%) -1.5M (-100.0%) 0.00% -0.859 pp 0.00% -0.004 pp USD 2 qtrs SOLD
76 XTX TOPCO LTD -20.3K (-100.0%) -490.4K (-100.0%) 0.00% -0.277 pp 0.00% -0.025 pp USD 2 qtrs SOLD
77 SUSQUEHANNA PORTFOLIO STRATEGIES, LLC -41.5K (-100.0%) -1.0M (-100.0%) 0.00% -0.566 pp 0.00% -0.016 pp USD 3 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 44 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Invesco NASDAQ Future Gen 200 ETF QQQS 0.51% 111.5K 0.20%
2 iShares Micro-Cap ETF IWC 0.04% 615.0K 0.60%
3 Fidelity Enhanced Small Cap ETF FESM 0.03% 1.50M 0.28%
4 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC 0.02% 210.5K 0.20%
5 iShares Russell 2000 Value ETF IWN 0.01% 1.81M 0.24%
6 Vanguard Russell 2000 Value ETF VTWV 0.01% 130.0K 0.06%
7 Invesco RAFI US 1500 Small-Mid ETF PRFZ 0.01% 270.4K 0.34%
8 State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L 0.01% 423.3K 0.30%
9 Avantis U.S. Small Cap Equity ETF AVSC 0.01% 191.2K 0.25%
10 iShares Russell 2000 BuyWrite ETF IWMW 0.01% 3.4K 0.39%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
12
Sells
0
Shares acquired
601.1K
Shares disposed
Cash buys
2.00
Cash sales
Net activity
+601,099
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-31 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,000 12.62 63.1K 20,001 I
2026-03-18 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 15,000 14.89 223.4K 15,001 I
2026-02-24 SULLIVAN GREGORY M Officer A-Award A Stock Option 39,012 14.29 557.5K 39,012 D
2026-02-24 SAENGER BRADLEY Officer A-Award A Stock Option 39,011 17.86 696.8K 39,011 D
2026-02-24 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 39,011 17.86 696.8K 39,011 D
2026-02-24 LEDERMAN SETH Director / Officer A-Award A Stock Option 134,503 17.86 2.40M 134,503 D
2026-02-24 Fogarty Siobhan Officer A-Award A Stock Option 39,011 17.86 696.8K 39,011 D
2025-12-31 SAENGER BRADLEY Officer / 10% Owner 0 0.00 0
2025-08-21 Taylor Carolyn E. Director P-Purchase A Common Stock, par value $0.001 418 36.03 15.1K 418 D
2025-08-20 Treco James Director P-Purchase A Common Stock, par value $0.001 250 36.00 9.0K 250 D
2025-06-12 Hunter James Randolph Jr Director Stock Option 7,740 34.54 267.3K 0 D
2025-05-15 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 4,000 21.55 86.2K 4,005 D
2025-05-13 Treco James Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 Taylor Carolyn E. Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 Stillwell Richard Newcomb Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 GRANGE DAVID L Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 Bell Margaret Smith Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-05-13 BAGGER RICHARD H Director A-Award A Stock Option 10,000 20.18 201.8K 10,000 D
2025-02-27 Fogarty Siobhan Officer Stock Option 26 1,177.60 30.6K 0 D
2025-02-25 SULLIVAN GREGORY M Officer A-Award A Stock Option 29,017 8.05 233.6K 29,017 D
2025-02-25 SAENGER BRADLEY Officer A-Award A Stock Option 25,792 8.05 207.6K 25,792 D
2025-02-25 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 29,291 10.06 294.7K 29,291 D
2025-02-25 LEDERMAN SETH Director / Officer A-Award A Stock Option 123,958 8.05 997.9K 123,958 D
2025-02-25 Fogarty Siobhan Officer A-Award A Stock Option 13,500 8.05 108.7K 13,500 D
2025-02-05 Treco James Director J-Other D Common Stock, par value $0.001 0 0.30 0.01 0 D
2025-02-05 SULLIVAN GREGORY M Officer J-Other D Common Stock, par value $0.001 0 1.47 0.16 0 D
2025-02-05 SAENGER BRADLEY Officer J-Other D Common Stock, par value $0.001 0 0.00 0 D
2025-02-05 MORRIS JESSICA EDGAR Officer J-Other D Common Stock, $0.001 par value 1 0.00 0 D
2025-02-05 LEDERMAN SETH Director / Officer J-Other D Common Stock, $0.001 par value 1 0.15 0.15 0 I
2025-02-05 Bell Margaret Smith Director J-Other D Common Stock, par value $0.001 1 0.15 0.15 0 D
2025-02-05 BAGGER RICHARD H Director J-Other D Common Stock, par value $0.001 0 0.20 0.00 0 D
2025-02-03 Fogarty Siobhan Officer Common Stock, $0.001 par value per share 0 0.00 1 D
2024-06-10 OLUKOTUN ADEOYE Y Director J-Other D Common Stock, par value $0.001 1 1.91 1.55 0 D
2024-06-06 Hunter James Randolph Jr Director Stock Option 2 6,240.00 12.5K 0 D
2024-05-23 Treco James Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 Taylor Carolyn E. Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 Stillwell Richard Newcomb Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 GRANGE DAVID L Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 Bell Margaret Smith Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-05-23 BAGGER RICHARD H Director A-Award A Stock Option 104,621 0.17 18.3K 104,621
2024-02-27 SULLIVAN GREGORY M Officer A-Award A Stock Option 358,000 0.37 131.7K 358,000
2024-02-27 SAENGER BRADLEY Officer A-Award A Stock Option 282,000 0.37 103.8K 282,000
2024-02-27 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 317,000 0.46 145.8K 317,000
2024-02-27 LEDERMAN SETH Director / Officer A-Award A Stock Option 235,320 0.37 86.6K 235,320
2024-02-23 Fogarty Siobhan Officer Stock Option 4 14,622.00 58.5K 0 D
2023-05-08 Treco James Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 Taylor Carolyn E. Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 Stillwell Richard Newcomb Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 GRANGE DAVID L Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 Bell Margaret Smith Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-05-08 BAGGER RICHARD H Director A-Award A Stock Option 60,000 0.51 30.5K 60,000
2023-03-15 Stillwell Richard Newcomb Director A-Award A Stock Option 83,000 0.56 46.6K 83,000
2023-02-23 SULLIVAN GREGORY M Officer A-Award A Stock Option 220,000 0.73 160.8K 220,000
2023-02-23 SAENGER BRADLEY Officer A-Award A Stock Option 200,000 0.73 146.2K 200,000
2023-02-23 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 207,500 0.91 189.7K 207,500
2023-02-23 LEDERMAN SETH Director / Officer A-Award A Stock Option 700,000 0.91 639.8K 700,000
2023-02-15 Fogarty Siobhan Officer Stock Option 1 132,352.00 132.4K 0 D
2022-06-29 LEDERMAN SETH Officer P-Purchase A Common Stock, $0.001 par value 20,000 1.71 34.2K 24,235
2022-05-09 Treco James Director A-Award A Stock Option 2,131,500 0.00 2,131,500
2022-05-09 Taylor Carolyn E. Director A-Award A Stock Option 2,131,500 0.00 2,131,500
2022-05-09 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 2,131,500 0.00 2,131,500
2022-05-09 GRANGE DAVID L Director A-Award A Stock Option 2,131,500 0.00 2,131,500
2022-05-09 Bell Margaret Smith Director A-Award A Stock Option 2,131,500 0.13 281.4K 2,131,500
2022-05-09 BAGGER RICHARD H Director A-Award A Stock Option 2,131,500 0.13 281.4K 2,131,500
2022-03-25 LEDERMAN SETH Officer P-Purchase A Common Stock, $0.001 par value 100,000 0.25 24.5K 112,177
2022-02-23 Fogarty Siobhan Officer Stock Option 1 780,800.00 780.8K 0 D
2022-02-15 SULLIVAN GREGORY M Officer A-Award A Stock Option 1,250,000 0.62 776.3K 1,250,000
2022-02-15 SAENGER BRADLEY Officer A-Award A Stock Option 900,000 0.83 745.2K 900,000
2022-02-15 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 1,100,000 0.21 227.7K 1,100,000
2022-02-15 LEDERMAN SETH Director / Officer A-Award A Stock Option 5,000,000 0.62 3.11M 5,000,000
2021-12-31 SULLIVAN GREGORY M Officer 0 0.00 0
2021-12-31 SAENGER BRADLEY Officer 0 0.00 0
2021-09-28 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 12,000 0.61 7.3K 12,177
2021-07-16 Taylor Carolyn E. Director D Stock Option 237,437 0.98 232.7K 0
2021-05-25 Goodman Daniel Wintner Director P-Purchase A Common Stock 5,000 1.12 5.6K 5,001
2021-05-10 Treco James Director A-Award A Stock Option 270,882 1.03 279.0K 270,882
2021-05-10 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 270,882 0.00 270,882
2021-05-10 Goodman Daniel Wintner Director A-Award A Stock Option 270,882 1.03 279.0K 270,882
2021-05-10 GRANGE DAVID L Director A-Award A Stock Option 270,882 1.03 279.0K 270,882
2021-05-10 Bell Margaret Smith Director A-Award A Stock Option 270,882 1.03 279.0K 270,882
2021-05-10 BAGGER RICHARD H Director A-Award A Stock Option 270,882 1.03 279.0K 270,882
2021-05-04 Fogarty Siobhan Officer Stock Option 1 492,800.00 492.8K 0 D
2021-05-04 BAGGER RICHARD H Director D Stock Option 68,750 0.71 48.8K 0
2021-03-24 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 16,733 1.32 22.1K 135,000
2021-02-25 Fogarty Siobhan Officer Stock Option 1 256,000.00 256.0K 0 D
2021-02-23 SULLIVAN GREGORY M Officer A-Award A Stock Option 750,000 1.53 1.15M 750,000
2021-02-23 SAENGER BRADLEY Officer A-Award A Stock Option 540,000 1.22 658.8K 540,000
2021-02-23 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 540,000 1.22 658.8K 540,000
2021-02-23 LEDERMAN SETH Director / Officer A-Award A Stock Option 3,000,000 1.22 3.66M 3,000,000
2021-01-07 SULLIVAN GREGORY M Officer A-Award A Common Stock, $0.001 par value 41,322 0.51 21.1K 62,727
2020-12-31 SAENGER BRADLEY Officer 0 0.00 0
2020-12-30 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 35,000 0.68 23.8K 118,267
2020-08-31 Treco James Director P-Purchase A Common Stock, par value $0.001 5,500 0.89 4.9K 10,000
2020-08-20 Bell Margaret Smith Director P-Purchase A Common Stock, par value $0.001 5,391 0.93 5.0K 5,391
2020-08-17 SULLIVAN GREGORY M Officer P-Purchase A Common Stock, par value $0.001 20,000 1.03 20.6K 21,405
2020-08-14 Treco James Director P-Purchase A Common Stock, par value $0.001 4,500 1.06 4.8K 4,500
2020-08-13 OLUKOTUN ADEOYE Y Director P-Purchase A Common Stock, par value $0.001 5,350 0.94 5.0K 5,350
2020-08-13 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 60,000 0.91 54.6K 83,267
2020-08-13 BAGGER RICHARD H Director P-Purchase A Common Stock, par value $0.001 10,000 0.91 9.1K 10,000
2020-06-09 BAGGER RICHARD H Director A-Award A Stock Option 68,750 0.71 48.8K 68,750
2020-05-06 Goodman Daniel Wintner Director D Stock Option 30,000 2.05 61.5K 0
2020-05-06 Fogarty Siobhan Officer Stock Option 1 13,120,000.00 13.12M 0 D
2020-05-04 Treco James Director A-Award A Stock Option 112,500 0.77 86.6K 112,500
2020-05-04 SULLIVAN GREGORY M Officer A-Award A Stock Option 500,000 0.77 385.0K 500,000
2020-05-04 SAENGER BRADLEY Officer A-Award A Stock Option 360,000 0.96 345.6K 360,000
2020-05-04 Rhodes John B Director A-Award A Stock Option 75,000 0.77 57.8K 75,000
2020-05-04 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 75,000 0.77 57.8K 75,000
2020-05-04 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 360,000 0.96 345.6K 360,000
2020-05-04 LEDERMAN SETH Officer A-Award A Stock Option 2,000,000 0.96 1.92M 2,000,000
2020-05-04 Goodman Daniel Wintner Director A-Award A Stock Option 75,000 0.77 57.8K 75,000
2020-05-04 GRANGE DAVID L Director A-Award A Stock Option 75,000 0.00 75,000
2020-05-04 Bell Margaret Smith Director A-Award A Stock Option 75,000 0.77 57.8K 75,000
2020-03-16 Treco James Director A-Award A Stock Option 6,000 0.53 3.2K 6,000
2020-02-26 Fogarty Siobhan Officer Stock Option 1 12,096,000.00 12.10M 0 D
2020-02-25 SULLIVAN GREGORY M Officer A-Award A Stock Option 39,000 0.40 15.6K 39,000
2020-02-25 SAENGER BRADLEY Officer A-Award A Stock Option 24,000 0.40 9.6K 24,000
2020-02-25 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 24,000 0.50 12.0K 24,000
2020-02-25 LEDERMAN SETH Director / Officer A-Award A Stock Option 120,000 0.50 60.0K 120,000
2019-12-31 SULLIVAN GREGORY M Officer 0 0.00 0
2019-12-31 SAENGER BRADLEY Officer 0 0.00 0
2019-12-03 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 20,000 1.16 23.2K 23,267
2019-05-06 Treco James Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-05-06 SULLIVAN GREGORY M Officer A-Award A Stock Option 43,252 2.56 110.7K 43,252
2019-05-06 SAENGER BRADLEY Officer A-Award A Stock Option 28,835 2.56 73.8K 28,835
2019-05-06 Rhodes John B Director A-Award A Stock Option 45,000 2.05 92.3K 45,000
2019-05-06 OLUKOTUN ADEOYE Y Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-05-06 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 28,835 2.05 59.1K 28,835
2019-05-06 LEDERMAN SETH Director / Officer A-Award A Stock Option 129,757 2.56 332.2K 129,757
2019-05-06 LANDRY DONALD W Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-05-06 Goodman Daniel Wintner Director D Common Stock, $0.001 par value 0 0.00 7
2019-05-06 GRANGE DAVID L Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-05-06 GRACE PATRICK P Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-05-06 Bell Margaret Smith Director A-Award A Stock Option 30,000 2.05 61.5K 30,000
2019-03-29 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,000 2.49 12.4K 32,670
2019-03-26 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 25,000 2.38 59.4K 27,670
2019-02-26 SULLIVAN GREGORY M Officer A-Award A Stock Option 7,755 1.89 14.7K 7,755
2019-02-26 SAENGER BRADLEY Officer A-Award A Stock Option 5,170 2.36 12.2K 5,170
2019-02-26 MORRIS JESSICA EDGAR Officer A-Award A Common Stock 5,170 2.36 12.2K 5,170
2019-02-26 LEDERMAN SETH Director / Officer A-Award A Stock Option 23,265 2.36 54.9K 23,265
2019-02-14 Treco James Director A-Award A Stock Option 10,000 1.86 18.6K 10,000
2019-02-13 Fogarty Siobhan Officer Stock Option 1 217,600,000.00 217.60M 0 D
2018-09-05 OLUKOTUN ADEOYE Y Director D Stock Option 15,000 1.03 15.5K 0
2018-06-29 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 500 4.64 2.3K 17,666
2018-06-28 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 500 4.58 2.3K 17,166
2018-06-27 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 500 4.55 2.3K 16,666
2018-06-25 MARIO ERNEST Director P-Purchase A Common Stock, $0.001 par value 16,500 4.48 73.9K 50,000
2018-06-14 SULLIVAN GREGORY M Officer P-Purchase A Common Stock, $0.001 par value 10,000 3.97 39.7K 20,482
2018-06-14 SAENGER BRADLEY Officer P-Purchase A Common Stock, $0.001 par value 300 4.10 1.2K 3,079
2018-06-14 MORRIS JESSICA EDGAR Officer P-Purchase A Common Stock, $0.001 par value 300 4.19 1.3K 1,638
2018-06-12 Saks Samuel R Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 Rhodes John B Director A-Award A Stock Option 30,000 4.25 127.5K 30,000
2018-06-12 MATHER CHARLES E IV Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 MARIO ERNEST Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 2,000 4.37 8.7K 20,463
2018-06-12 LANDRY DONALD W Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 GRANGE DAVID L Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 GRACE PATRICK P Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-12 Bell Margaret Smith Director A-Award A Stock Option 20,000 4.25 85.0K 20,000
2018-06-08 GRANGE DAVID L Director D Stock Option 7,000 3.40 23.8K 0
2018-06-01 Rhodes John B Director P-Purchase A Common Stock, $0.001 par value 7,500 3.33 25.0K 23,470
2018-05-25 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 4,000 3.17 12.7K 26,700
2018-03-01 MORRIS JESSICA EDGAR Officer D Stock Option 9,000 5.50 49.5K 0
2018-03-01 Fogarty Siobhan Officer Stock Option 1 352,000,000.00 352.00M 0 D
2018-02-27 MATHER CHARLES E IV Director M-Exempt A Common Stock, $0.001 par value 750 0.00 12,580
2018-02-13 SULLIVAN GREGORY M Officer A-Award A Stock Option 58,726 3.40 199.7K 58,726
2018-02-13 SAENGER BRADLEY Officer A-Award A Stock Option 39,150 3.40 133.1K 39,150
2018-02-13 MORRIS JESSICA EDGAR Officer A-Award A Stock Option 39,150 4.25 166.4K 39,150
2018-02-13 LEDERMAN SETH Director / Officer A-Award A Stock Option 156,601 4.25 665.6K 156,601
2018-02-13 GRANGE DAVID L Director A-Award A Stock Option 7,000 3.40 23.8K 7,000
2018-02-09 MARIO ERNEST Director G-Gift D Common Stock, $0.001 par value 10,000 0.00 0
2017-12-26 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,300 3.61 19.1K 22,700
2017-12-21 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 5,000 3.46 17.3K 23,500
2017-12-20 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 8,965 3.44 30.8K 28,500
2017-12-19 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 6,035 3.51 21.2K 37,465
2017-12-18 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 10,000 3.57 35.7K 43,500
2017-12-15 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 5,000 3.55 17.8K 53,500
2017-12-14 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 1,967 3.58 7.0K 55,467
2017-09-12 Bell Margaret Smith Director D Stock Option 20,000 4.25 85.0K 0
2017-08-17 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 15,000 3.00 45.1K 50,000
2017-08-16 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,000 2.99 15.0K 35,000
2017-06-30 MARIO ERNEST Director S-Sale D Common Stock, $0.001 par value 6,105 4.28 26.1K 5,895
2017-06-30 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,000 4.33 21.6K 30,000
2017-06-26 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 5,000 4.40 22.0K 25,000
2017-06-20 Saks Samuel R Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-06-20 Rhodes John B Director A-Award A Stock Option 30,000 4.18 125.4K 30,000
2017-06-20 MATHER CHARLES E IV Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-06-20 MARIO ERNEST Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-06-20 LEDERMAN SETH Director / Officer P-Purchase A Common Stock, $0.001 par value 20,000 4.22 84.4K 20,000
2017-06-20 LANDRY DONALD W Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-06-20 GRACE PATRICK P Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-06-20 DAVIDSON STUART Director A-Award A Stock Option 20,000 4.18 83.6K 20,000
2017-05-27 Saks Samuel R Director M-Exempt A Common Stock, $0.001 par value 750 0.00 6,605
2017-05-27 Rhodes John B Director M-Exempt A Common Stock, $0.001 par value 1,125 0.00 15,970
2017-05-27 MATHER CHARLES E IV Director M-Exempt A Common Stock, $0.001 par value 750 0.00 3,283
2017-05-27 MARIO ERNEST Director M-Exempt A Common Stock, $0.001 par value 750 0.00 64,572
2017-05-27 LANDRY DONALD W Director M-Exempt A Common Stock, $0.001 par value 750 0.00 9,210
2017-05-27 GRACE PATRICK P Director M-Exempt A Common Stock, $0.001 par value 750 0.00 2,755

Executive team

Top executives
EBIT / Employee
-15.5K
Shares Outstanding
14.21M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Seth Lederman Chief Executive Officer 702.0K 596.7K 1.87M 3.17M 59.02%
2 2025 Jessica Morris Chief Operations Officer 522.9K 261.5K 441.9K 1.23M 36.04%
3 2025 Gregory Sullivan Chief Medical Officer 519.2K 259.6K 437.8K 1.22M 35.99%
4 2025 Bradley Saenger Chief Financial Officer 502.9K 251.5K 389.1K 1.14M 34.03%
5 2024 Seth Lederman Chief Executive Officer 675.0K 417.7K 717.1K 1.81M 39.62%
6 2024 Gregory Sullivan Chief Medical Officer 499.2K 182.2K 241.0K 922.4K 26.13%
7 2024 Jessica Morris Chief Operations Officer 494.0K 180.3K 213.4K 887.7K 24.04%
8 2024 Bradley Saenger Chief Financial Officer 483.6K 176.5K 189.9K 850.0K 22.34%
9 2023 Seth Lederman Chief Executive Officer 675.0K 1.38M 2.05M 67.07%
10 2023 Gregory Sullivan Chief Medical Officer 480.0K 181.4K 290.6K 952.0K 30.52%
11 2023 Jessica Morris Chief Operations Officer 475.0K 179.6K 274.0K 928.6K 29.51%
12 2023 Bradley Saenger Chief Financial Officer 465.0K 175.8K 264.1K 904.9K 29.19%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-03-30 DEF 14A
2026-03-20 PRE 14A
2025-03-31 DEF 14A
2025-03-21 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-11 8-K
2026-05-11 10-Q
2026-05-07 8-K
2026-05-06 8-K
2026-05-01 8-K
2026-04-29 8-K
2026-04-23 8-K
2026-04-01 4
2026-03-31 8-K
2026-03-30 DEF 14A

Executive team

NameTitleCompensationGender
Seth Lederman Co-Founder, President, Chief Executive Officer & Chairman 1M
Mrs. Jessica Edgar Morris Chief Operating Officer 784.4K
Gregory Sullivan Chief Medical Officer & Secretary 778.8K
Bradley Saenger Chief Financial Officer & Treasurer 754.4K male
Irina Ishak General Counsel female
Ganesh Kamath Head of Market Access male
Darryl Rideout Executive Vice President of Experimental Chemistry
Sina Bavari Executive Vice President of Infectious Disease Research & Development
Siobhan Fogarty Chief Technical Officer female
Thomas Englese Executive Vice President of Commercial Operations male
Zeil Rosenberg Executive Vice President of Medical
ESG Rating
B
BIOTECHNOLOGY
Rank: 564 out of 710
2024
E (Environmental)
66.6 / 56.3
Company / Sector avg.
S (Social)
65.3 / 62.4
Company / Sector avg.
G (Governance)
67.8 / 60.9
Company / Sector avg.
ESG Total
66.6 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits